Cancer Patients Have Lower Antibody Titers against Coronavirus: NCC

June 3, 2021
The National Cancer Center (NCC) said on June 2 that its study showed no difference in the coronavirus antibody prevalence rate between cancer patients and healthy individuals but lower antibody titers in the former group apparently due to anticancer drug...read more